To confirm the binding affinity to GPRC5D, we performed FCM analysis using KMS-11 and KMS-26 cells as GPRC5D-negative and positive cells, respectively, in accordance with the expression data of the Cancer Dependency Map25. The gene discussed is GPRC5D; the disease is cancer.